The Amsterdam universities always have collaboration or licensing opportunities available. Find an overview below and select an opportunity if you want read the factsheet (PDF) with detailed information.
The Amsterdam imaging core that offers access to both conventional (3 Tesla) and ultra- high field (7 Tesla) MRI facilities for fundamental and clinical research into the workings of the brain and brain disorders.
Drug target discovery in neuroscience is increasingly relying on human samples to generate meaningful data that translates into actionable strategies. Open access to well-characterized brain tissue of high quality is crucial to obtain these insights and is the goal of the Netherlands Brain Bank.
The Dutch healthtech company Nico.lab prepares for an IPO in Australia after the company has previously collected 3 million euros from Australian investors. In addition, Nico.lab will enter the US market. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC. With years of intensive clinical research in the […]News
Scientists are now able to view live molecular interactions as they would occur in the body, thanks to a unique partnership between AstraZeneca, LUMICKS and the University of Cambridge. The world’s first centre for dynamic single-molecule analysis has been established at the university’s Department of Biochemistry on Tennis Court Road to help accelerate drug discovery. […]News
On Monday January 28th 2019, Innovation Exchange Amsterdam (IXA office UvA-HvA) and the UvA Institute for Advanced Study (IAS) jointly organised the 6th Barlaeus dinner at the Allard Pierson Museum. The central question of the evening was: what is effective and responsible policy/governance in an increasingly complex and rapidly changing world? Complexity is a feature […]News